• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病相关知识对丙型肝炎病毒 (HCV) 感染者污名感知的影响。

The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection.

机构信息

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.

Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, United States of America.

出版信息

PLoS One. 2021 Oct 5;16(10):e0258143. doi: 10.1371/journal.pone.0258143. eCollection 2021.

DOI:10.1371/journal.pone.0258143
PMID:34610030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8491913/
Abstract

Most patients with hepatitis C virus (HCV) infection perceive some degree of disease-related stigma. Misunderstandings about diseases may contribute to disease-related stigma. The objective of this study was to evaluate patient-level knowledge about HCV infection transmission and natural history and its association with HCV-related stigma among HCV-infected patients. We conducted a cross-sectional survey study among 265 patients with HCV in Philadelphia using the HCV Stigma Scale and the National Health and Nutrition Examination Survey (NHANES) Hepatitis C Follow-up Survey (2001-2008). The association between HCV knowledge and HCV-related stigma was evaluated via linear regression. Overall knowledge about HCV transmission and natural history was high, with >80% of participants answering ≥9 of 11 items correctly (median number of correct responses, 9 [82%]), HCV-related knowledge was similar between HIV/HCV-coinfected and HCV-monoinfected participants (p = 0.30). A higher level of HCV-related knowledge was associated with greater perceived HCV-related stigma (β, 2.34 ([95% CI, 0.51-4.17]; p = 0.013). Results were similar after adjusting for age, race, ethnicity, HIV status, education level, stage of HCV management, time since diagnosis, and history of injection drug use. In this study, increased HCV-related knowledge was associated with greater perceptions of HCV stigma. Clinicians may consider allotting time to address common misconceptions about HCV when educating patients about HCV infection, which may counterbalance the stigmatizing impact of greater HCV-related knowledge.

摘要

大多数丙型肝炎病毒 (HCV) 感染者都能感受到某种程度的与疾病相关的耻辱感。对疾病的误解可能导致与疾病相关的耻辱感。本研究的目的是评估 HCV 感染患者对 HCV 传播和自然史的个体认知水平及其与 HCV 相关耻辱感的关系。我们对费城的 265 名 HCV 感染者进行了一项横断面调查研究,使用 HCV 耻辱量表和全国健康和营养检查调查 (NHANES) HCV 随访调查 (2001-2008)。通过线性回归评估 HCV 知识与 HCV 相关耻辱感之间的关联。总体而言,对 HCV 传播和自然史的了解程度较高,超过 80%的参与者答对了 11 个问题中的 9 个或以上(中位数答对的问题数为 9 [82%]),HIV/HCV 合并感染和 HCV 单感染患者之间的 HCV 相关知识相似(p = 0.30)。较高的 HCV 相关知识水平与更大的 HCV 相关耻辱感感知相关(β,2.34 [95%CI,0.51-4.17];p = 0.013)。调整年龄、种族、民族、HIV 状态、教育水平、HCV 管理阶段、诊断后时间和注射吸毒史后,结果相似。在这项研究中,增加的 HCV 相关知识与更大的 HCV 耻辱感感知相关。临床医生在向 HCV 感染者讲授 HCV 感染时,可能会考虑留出时间来解决对 HCV 的常见误解,这可能会抵消对 HCV 相关知识增加的耻辱感的负面影响。

相似文献

1
The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection.疾病相关知识对丙型肝炎病毒 (HCV) 感染者污名感知的影响。
PLoS One. 2021 Oct 5;16(10):e0258143. doi: 10.1371/journal.pone.0258143. eCollection 2021.
2
Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection.验证改良的 Berger HIV 耻辱量表在丙型肝炎病毒(HCV)感染患者中的适用性。
PLoS One. 2020 Feb 5;15(2):e0228471. doi: 10.1371/journal.pone.0228471. eCollection 2020.
3
Determinants of stigma among patients with hepatitis C virus infection.丙型肝炎病毒感染者污名的决定因素。
J Viral Hepat. 2020 Nov;27(11):1179-1189. doi: 10.1111/jvh.13343. Epub 2020 Jun 23.
4
Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians.评估埃及 HCV 感染者对丙型肝炎感染的了解程度和可用信息来源。
BMC Public Health. 2018 Jun 18;18(1):747. doi: 10.1186/s12889-018-5672-6.
5
Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.直接和间接的社会及空间关系在注射吸毒人群中 HIV 和 HCV 传播中的作用:印度新德里基于社区的横断面网络分析
Elife. 2021 Aug 3;10:e69174. doi: 10.7554/eLife.69174.
6
An investigation of stigmatizing attitudes towards people living with HIV/AIDS by doctors and nurses in Vientiane, Lao PDR.老挝万象医生和护士对艾滋病毒/艾滋病感染者的污名化态度调查。
BMC Health Serv Res. 2017 Feb 10;17(1):125. doi: 10.1186/s12913-017-2068-8.
7
Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.印度基于社区的注射吸毒人群中药物使用污名与丙型肝炎病毒感染和注射吸毒行为的关联。
Int J Drug Policy. 2021 Oct;96:103354. doi: 10.1016/j.drugpo.2021.103354. Epub 2021 Jul 8.
8
Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.印度钦奈注射吸毒人群中的丙型肝炎关怀连续体及相关障碍。
Int J Drug Policy. 2018 Jul;57:51-60. doi: 10.1016/j.drugpo.2018.03.023. Epub 2018 Apr 19.
9
High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan.台湾地区人类免疫缺陷病毒感染者中丙型肝炎病毒感染者与非感染者对丙型肝炎病毒感染状态认知率均较高。
PLoS One. 2021 May 6;16(5):e0251158. doi: 10.1371/journal.pone.0251158. eCollection 2021.
10
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.纳入长期随访方案的围产期感染人类免疫缺陷病毒儿童的丙型肝炎患病率。
Arch Pediatr Adolesc Med. 2004 Oct;158(10):1007-13. doi: 10.1001/archpedi.158.10.1007.

引用本文的文献

1
A review of historical landmarks and pioneering technologies for the diagnosis of Hepatitis C Virus (HCV).丙型肝炎病毒(HCV)诊断的历史里程碑与开创性技术综述
Eur J Clin Microbiol Infect Dis. 2025 Mar 22. doi: 10.1007/s10096-025-05110-y.
2
Stigma in steatotic liver disease: A survey of patients from Saudi Arabia.脂肪变性肝病的耻辱感:来自沙特阿拉伯的患者调查。
Saudi J Gastroenterol. 2024 Sep 1;30(5):335-341. doi: 10.4103/sjg.sjg_122_24. Epub 2024 Aug 22.
3
Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil.巴西南部一家医院慢性丙型肝炎患者的护理阶段。
World J Hepatol. 2023 Aug 27;15(8):973-984. doi: 10.4254/wjh.v15.i8.973.
4
Factors associated with COVID-19 stigma during the onset of the global pandemic in India: A cross-sectional study.与印度全球大流行期间 COVID-19 污名相关的因素:一项横断面研究。
Front Public Health. 2022 Oct 14;10:992046. doi: 10.3389/fpubh.2022.992046. eCollection 2022.
5
Decision-making Among Hepatitis C Virus-negative Transplant Candidates Offered Organs from Donors with HCV Infection.丙型肝炎病毒阴性的移植受者在获得来自丙型肝炎病毒感染供体的器官时的决策制定。
Transplant Direct. 2022 Jul 19;8(8):e1341. doi: 10.1097/TXD.0000000000001341. eCollection 2022 Aug.

本文引用的文献

1
"Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.“污名化才是伤害的根源”:探索注射吸毒者丙型肝炎病毒治疗后轨迹的预期和生活体验。
Int J Drug Policy. 2021 Oct;96:103238. doi: 10.1016/j.drugpo.2021.103238. Epub 2021 Apr 23.
2
Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.在押囚犯对直接作用抗病毒丙型肝炎治疗的认知、态度和可接受性:一项定性研究。
PLoS One. 2020 Dec 2;15(12):e0242623. doi: 10.1371/journal.pone.0242623. eCollection 2020.
3
Determinants of stigma among patients with hepatitis C virus infection.丙型肝炎病毒感染者污名的决定因素。
J Viral Hepat. 2020 Nov;27(11):1179-1189. doi: 10.1111/jvh.13343. Epub 2020 Jun 23.
4
Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection.验证改良的 Berger HIV 耻辱量表在丙型肝炎病毒(HCV)感染患者中的适用性。
PLoS One. 2020 Feb 5;15(2):e0228471. doi: 10.1371/journal.pone.0228471. eCollection 2020.
5
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study.保险公司完全拒绝丙型肝炎直接抗病毒治疗:一项全国专科药房队列研究。
Open Forum Infect Dis. 2018 Jun 7;5(6):ofy076. doi: 10.1093/ofid/ofy076. eCollection 2018 Jun.
6
Hepatitis C treatment: where are we now?丙型肝炎治疗:我们目前处于什么阶段?
Int J Gen Med. 2017 Feb 17;10:39-52. doi: 10.2147/IJGM.S127689. eCollection 2017.
7
Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance.按保险类型划分的现代丙型肝炎治疗绝对拒绝率的差异
Clin Gastroenterol Hepatol. 2016 Jul;14(7):1035-43. doi: 10.1016/j.cgh.2016.03.040. Epub 2016 Apr 5.
8
The Hepatitis C treatment experience: Patients' perceptions of the facilitators of and barriers to uptake, adherence and completion.丙型肝炎治疗经历:患者对治疗接受、依从性和完成治疗的促进因素及障碍的看法。
Psychol Health. 2015;30(8):987-1004. doi: 10.1080/08870446.2015.1012195. Epub 2015 Feb 23.
9
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.美国慢性丙型肝炎病毒感染的治疗流程:一项系统评价与荟萃分析
PLoS One. 2014 Jul 2;9(7):e101554. doi: 10.1371/journal.pone.0101554. eCollection 2014.
10
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes.丙型肝炎防治链:确定改善临床结局的优先事项。
PLoS One. 2014 May 19;9(5):e97317. doi: 10.1371/journal.pone.0097317. eCollection 2014.